Simple Summary Over the past decade, cell-based immunotherapy has become a powerful
strategy in solid cancer therapy. Tumor-infiltrating lymphocytes (TILs) are a group of …

Drug repurposing, also known as drug repositioning, entails the application of pre-approved
or formerly assessed drugs having potentially functional therapeutic amalgams for curing …

Simple Summary CAR-T cells are immune cells equipped with a claw that enable them to
bind cancer cells. Usually, CAR-T cells are made using immune cells from blood. Here, we …

Allogeneic T cells are key immune therapeutic cells to fight cancer and other clinical
indications. High T cell dose per patient and increasing patient numbers result in clinical …

Introduction As one of the most efficacious methods of cancer immunotherapy, chimeric
antigen receptor-modified immune cells have recently drawn enormous attention. After the …

Lung cancer is an imminent health threat and the predominant cause of cancer-related
fatalities worldwide. Significant advancements in identifying important mutational variations …

Cancer immunotherapy is undergoing rapid development. Numerous preclinical and clinical
trials are in progress. In general terms, immunotherapy includes non-specific stimulation of …

The success of immune checkpoint inhibitors (ICIs) has established the importance of
cancer immunotherapy in solid cancers, where it has been adopted as one of the standards …